Edited by XI Yue (Andie)

On June 8 and 9, an international conference on hepatobiliary and pancreatic diseases was hosted at Qingchun Campus of Sir Run Run Shaw Hospital (SRRSH), affiliated with Zhejiang University School of Medicine. Dr. Michael L. Kendrick, Dr. Robert R. McWilliams, and Dr. Michael G. Haddock, oncologists from Mayo Clinic in the United States were invited to attend the meeting. Other renowned domestic participants included Dr. Shen Boyong, Vice President of Ruijin Hospital, affiliated to Shanghai Jiaotong University School of Medicine, Dr. Zhang Zhigang, researcher of Shanghai Cancer Institute, Dr. Yin Dalong, Vice President of the First Affiliated Hospital of University of Science and Technology of China, Dr. Liu Wei from the Second Xiangya Hospital of Central South University, and SRRSH experts. Presenters shared excellent reports on minimally invasive surgical treatment, systematic comprehensive treatment, life cycle management of pancreatic cancer, and environmental regulation mechanisms of pancreatic cancer. A spirited discussion sprang up.

On the afternoon of June 8, SRRSH and Mayo Clinic jointly held a multidisciplinary clinical consultation seminar, offering public benefit services for Chinese patients with severe or difficult pancreatic diseases. “Face to Face with Renowned Chinese and American Doctors: the Diagnosis and Treatment of Pancreatic Cancer, ‘the King of Cancers’”, a popular medical science public benefit activity was carried out later. The team from Mayo Clinic also participated in ward rounds as guiding experts.

Dr. CAI Xiujun, President of SRRSH, said that as the one and only public hospital member of Mayo Clinic Care Network, SRRSH has maintained long-sustained close cooperation with Mayo Clinic. This international conference on hepatobiliary and pancreatic diseases collected society-wide difficult cases in the early stage. It not only helps to improve diagnosis and treatment capacity, but also delivers cutting-edge international medical services to the general public in China.

According to Dr. YU Hong, SRRSH established the Severe and Acute Pancreatitis (SAP) Center and the Pancreatic Tumor MDT Center by drawing together several preponderant disciplines, including minimally invasive surgery, hepatobiliary and pancreatic surgery, radiology, oncology, endoscopic therapy, radiotherapy, and intensive care unit. Meanwhile, through establishing a diagnosis and treatment alliance for severe pancreatic cancers with hospitals at all levels inside and outside Zhejiang province, SRRSH compiled the Consensus on the Diagnosis and Treatment of Severe Pancreatitis in Zhejiang Province and set up clinical databases. The hospital receives over 200 cases of severe and acute pancreatic cancer annually, with a leading 92%-odd overall cure rate nationally.